Teligent Inc (TLGT)

Overview

Teligent, Inc., previously recognized as Igi Laboratories Inc, operates as a specialized entity within the generic pharmaceutical sector. The company markets and distributes its own brand of generic injectable medications across the United States and Canada. By the end of 2018, Teligent's offerings in the U.S. encompassed 35 generic topical drugs alongside four branded generic pharmaceutical products. In addition to its proprietary product lines, Teligent extends its services to include development, formulation, and manufacturing expertise tailored to the pharmaceutical industry, over-the-counter (OTC) goods, and cosmetic sectors. The company is strategically dedicated to creating, producing, and promoting a diverse range of generic pharmaceuticals, with various modes of delivery including topical, injectable, complex, and ophthalmic preparations. Furthermore, Teligent is actively engaged in a business segment focused on contract manufacturing and formulation services. As of December 31, 2018, the company had begun the process of filing 20 Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration (FDA), indicating its commitment to expanding its portfolio of pharmaceutical offerings in the future.

Products and Services

• Generic Injectable Medications

  Teligent offers a wide range of generic injectable medications that are marketed under the Teligent brand. These products are designed to provide quality therapeutic options to healthcare providers and patients across the United States and Canada.

• Generic Topical Drugs

  As of 2018, Teligent's portfolio included 35 generic topical drugs that cater to various therapeutic needs. These products are formulated to be safe and effective alternatives to brand-name drugs, providing cost-effective solutions in the pharmaceutical market.

• Branded Generic Pharmaceuticals

  The company also offers four branded generic pharmaceutical items. These products combine brand recognition with the affordability of generic options, appealing to a broader range of consumers and healthcare practitioners.

• Development Services

  Teligent provides extensive development services aimed at formulating and enhancing pharmaceutical products, ensuring they meet the regulatory standards and market demands.

• Formulation Expertise

  The company offers formulation expertise to assist clients in developing effective pharmaceutical, OTC, and cosmetic products, tailored to their specific requirements and market challenges.

• Contract Manufacturing

  Teligent’s contract manufacturing segment provides clients with efficient production capabilities, enabling the manufacturing of pharmaceutical products according to their specifications and quality standards.

• Future Product Pipeline

  The company is committed to innovation, with a future product pipeline that as of the end of 2018 included 20 ANDAs filed with the FDA. This dedication to expanding its offerings emphasizes Teligent's strategic growth in the generic pharmaceutical landscape.